NIH Criticized for Labeling Gain-of-Function Research as Dangerous

Sarah Stanley, a UC Berkeley researcher, criticizes the NIH's decision to halt her TB research, arguing that the work involves standard, safe techniques that are crucial for developing treatments and that the broad classification of her work as 'dangerous' is misleading and could hinder important medical progress.